"Jubilant Pharma, a material wholly owned subsidiary of Jubilant Life Sciences, through one of its wholly owned subsidiaries, has signed an asset purchase agreement with Triad Isotopes Inc. and its parent, Isotope Holdings, Inc. to acquire substantially all of the assets which comprise the radiopharmacy business of Triad," as per company release.
The acquisition will facilitate Jubilant forward integrate in the radiopharmaceutical business, thereby helping it better directly serve healthcare providers and their patients with high quality radiopharmaceutical products.
No comments:
Post a Comment